02.11.2018
- Paolo Magri, senior vice president, business development at Advitech, has been elected president of the Drug, Chemical & Associated Technologies Association (DCAT). Also elected to...
23.08.2018
- After two years of trying, Israeli generics producer Teva Pharmaceutical Industries has finally gained approval by the US Food and Drug Administration (FDA) for its copy of Mylan’s...
04.06.2018
- Mylan is leaning on Pfizer to do more to relieve shortages of the EpiPen Auto-Injector. Although the drugmaker based in the US and the UK owns the rights to the EpiPen, which is...
26.04.2018
- Mylan has joined forces with Japan’s Fujifilm Kyowa Kirin Biologics to commercialize a biosimilar to Abbvie’s Humira (adalimumab) that has been developed by the Japanese company...
07.12.2017
- The US Food and Drug Administration (FDA) has given the green light to Netherlands-domiciled, US-managed generic drugmaker Mylan’s Ogivri (trastuzumab-dkst) breast cancer drug, a...
04.12.2017
- Kåre Schultz, new chief executive officer of debt-plagued Israeli drugmaker Teva, is moving rapidly to make good on his pledge to improve the company’s financial performance and...
07.11.2017
- Sanofi is pursuing another US competitor for alleged breach of the patent for its top-selling diabetes drug insulin glargine (branded as Lantus and Lantus SoloStar), which together...
28.09.2017
- UK-based specialty pharmaceuticals company Indivior, formerly part of Reckitt Benckiser, has reached an-out of-court settlement with Mylan Pharmaceuticals, which was planning to...
